Samsung Biologics Union Launches First-Ever Full-Scale Strike Since Founding (Comprehensive)
2,500 Participate Using Annual Leave from May 1 to 5
Concerns Mount Over Production Disruptions Amid Wage Negotiation Deadlock
Company Says "Losses Already Exceed 150 Billion Won"
Central Regional Employment and Labor Office to Mediate Talks on May 4
As Samsung Biologics' labor union launched its first-ever full-scale strike since the company's founding in 2011, it has been revealed that the company's losses have already exceeded 150 billion won. With wage and collective bargaining negotiations still deadlocked and disruptions to biopharmaceutical production now materializing, concerns within the industry are mounting.
On the 30th, one day before the strike of the Samsung Biologics Labor Union, the union flag was hung at the Samsung Biologics plant in Yeonsu-gu, Incheon. Photo by Yonhap News
View original imageAccording to industry sources on May 1, the Samsung Biologics branch of the Samsung Group's umbrella labor union began a five-day full-scale strike from this day until May 5. The union has approximately 4,000 members, accounting for 73% of all employees, with about 2,500 reportedly expressing their intention to participate in the strike. Instead of organizing separate collective actions during the strike, the union opted to use annual leave, taking advantage of the extended holiday period that includes Labor Day, the weekend, and Children's Day. The company stated, "Due to the nature of this strike, which utilizes annual leave, it is difficult to determine the exact number of participants."
The root of the dispute lies in irreconcilable differences between labor and management over wage increases and personnel system reforms. Since December last year until negotiations broke down on March 23, labor and management held thirteen bargaining sessions and two meetings between the CEOs, but failed to reach an agreement. The union is demanding an average wage increase of around 14%, a bonus of 30 million won per employee, and prior union agreement on all aspects of the personnel system, including recruitment and promotion. The company, on the other hand, stated, "The union's demands are realistically difficult to meet considering the company's current capacity to pay and the need to secure resources for future growth," and has proposed a wage increase of 6.2%.
The full-scale strike is being carried out in the production, quality control (QC), quality assurance (QA), contract development (CDO), and process facility departments. Although the court has prohibited strike action among staff involved in the final three production processes—such as concentration and buffer exchange—to prevent drug spoilage, these employees are still at work. However, due to the nature of biopharmaceutical production, where the entire process from cell thawing to filling must be controlled continuously, production disruptions are occurring. The company said in an official statement, "Since the preemptive strike in the material sub-packing department began on April 28, essential raw and subsidiary materials have not been supplied in a timely manner. Despite emergency measures utilizing available personnel, production of some batches had to be inevitably halted, resulting in estimated losses of about 150 billion won."
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Samsung Biologics stated, "We take full responsibility for the production disruptions caused by the strike and are focusing all our efforts on preventing further damage and normalizing the business environment." The company also emphasized, "We will sincerely participate in the dialogue scheduled for May 4, mediated by the Central Regional Employment and Labor Office." In contrast, union leader Park Jaesung remarked, "The company, which cannot cope even with partial strikes, seems to have no way to prevent the full strike," suggesting that there may be continued difficulties before the plant returns to normal operations.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.